Medication Cost-Savings and Utilization of Generic Inhaled Corticosteroid (ICS) and Long-Acting Beta-Agonist (LABA) Drug Products in the USA
Crossref DOI link: https://doi.org/10.1007/s43441-021-00372-y
Published Online: 2022-02-03
Published Print: 2022-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Zhong
Ahluwalia, Sharon K.
Newman, Bryan
Dhapare, Sneha
Zhao, Liang
Luke, Markham C.
Text and Data Mining valid from 2022-02-03
Version of Record valid from 2022-02-03
Article History
Received: 22 October 2021
Accepted: 20 December 2021
First Online: 3 February 2022
Declarations
:
: Authors report no conflict of interest.